Meeting Coverage:

EURETINA Congress

EURETINA: 2022

Gearing Up for a GA Therapy

Show Description +

Anat Loewenstein, MD, MHA, talks with Kourous A. Rezaei, MD, about the potential treatments for geographic atrophy in the works and what retina specialists will need to do if they get approved.

Posted: 10/10/2022

Up Next

Using AI for DR Screening in India

S. Natarajan, MBBS, DO, FICO (UK), FVRS; and Andrzej Grzybowski, MD, PhD, MBA


Steps to Achieving the Impossible in DR Management

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Treating Traumatic Aphakia and Aniridia

Matteo Forlini, MD; and Mario R. Romano, MD, PhD

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

A Word From Euretina's President

Alistair Laidlaw, MBBS, MD

Gearing Up for a GA Therapy

Anat Loewenstein, MD, MHA, talks with Kourous A. Rezaei, MD, about the potential treatments for geographic atrophy in the works and what retina specialists will need to do if they get approved.

Posted: 10/10/2022


Please log in to leave a comment.

More From EURETINA: 2022 Coverage

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Treating Traumatic Aphakia and Aniridia

Matteo Forlini, MD; and Mario R. Romano, MD, PhD

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA